A formulation manufacturing facility of Aurobindo Pharma subsidiary Eugia Pharma Specialities in Rajasthan has been issued nine observations by the U.S. Food and Drug Administration. The U.S. FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results